Silo Pharma, Inc. · NASDAQ:SILO
Anson Funds Management LP's stake in Silo Pharma, Inc. fell to 4.90% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Anson Funds Management LP's stake in Silo Pharma, Inc. fell to 4.90%, 699,486 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 699,486
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Anson Funds Management LP | 4.90% | 699,486 |
| Anson Management GP LLC | 4.90% | 699,486 |
| Tony Moore | 4.90% | 699,486 |
| Anson Advisors Inc. | 4.90% | 699,486 |
| Amin Nathoo | 4.90% | 699,486 |
| Moez Kassam | 4.90% | 699,486 |
Source
Related
- Silo Pharma, Inc.
- Anson Funds Management LP
- Silo Pharma, Inc. shareholders
- Schedule 13G · Anson Funds Management LP · Nov 14, 2025
- Schedule 13G/A · SEG Opportunity Fund, LLC · Feb 13, 2026
- Schedule 13G/A · Mitchell P. Kopin · Feb 13, 2026
- Schedule 13G/A · Mitchell P. Kopin · Nov 7, 2025
- Schedule 13G · SEG Opportunity Fund, LLC · Oct 3, 2025
- Schedule 13G/A · Mitchell P. Kopin · Aug 12, 2025